304 related articles for article (PubMed ID: 25942537)
21.
Buscarlet M; Provost S; Zada YF; Barhdadi A; Bourgoin V; Lépine G; Mollica L; Szuber N; Dubé MP; Busque L
Blood; 2017 Aug; 130(6):753-762. PubMed ID: 28655780
[TBL] [Abstract][Full Text] [Related]
22. Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia.
Abdel-Wahab O; Levine RL
Blood; 2013 May; 121(18):3563-72. PubMed ID: 23640996
[TBL] [Abstract][Full Text] [Related]
23. Mutations in epigenetic modifiers in acute myeloid leukemia and their clinical utility.
Hou HA; Tien HF
Expert Rev Hematol; 2016 May; 9(5):447-69. PubMed ID: 26789100
[TBL] [Abstract][Full Text] [Related]
24. [Epigenetic dysregulation in myelodysplastic syndromes].
Sashida G
Rinsho Ketsueki; 2017; 58(10):1809-1817. PubMed ID: 28978819
[TBL] [Abstract][Full Text] [Related]
25. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
[TBL] [Abstract][Full Text] [Related]
26. Disturbing the histone code in leukemia: translocations and mutations affecting histone methyl transferases.
Chopra M; Bohlander SK
Cancer Genet; 2015 May; 208(5):192-205. PubMed ID: 25592767
[TBL] [Abstract][Full Text] [Related]
27. Epigenetics: reversible tags.
Wright J
Nature; 2013 Jun; 498(7455):S10-1. PubMed ID: 23803942
[No Abstract] [Full Text] [Related]
28. Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models.
Ono R; Masuya M; Inoue N; Shinmei M; Ishii S; Maegawa Y; Maharjan BD; Katayama N; Nosaka T
PLoS One; 2021; 16(3):e0248425. PubMed ID: 33705482
[TBL] [Abstract][Full Text] [Related]
29. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
Kn H; Bassal S; Tikellis C; El-Osta A
Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.
Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y
J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896
[TBL] [Abstract][Full Text] [Related]
31. Epigenetics of hematopoiesis and hematological malignancies.
Hu D; Shilatifard A
Genes Dev; 2016 Sep; 30(18):2021-2041. PubMed ID: 27798847
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of epigenetic regulation of leukemia onset and progression.
Ntziachristos P; Mullenders J; Trimarchi T; Aifantis I
Adv Immunol; 2013; 117():1-38. PubMed ID: 23611284
[TBL] [Abstract][Full Text] [Related]
33. Alterations to
Venugopal K; Feng Y; Shabashvili D; Guryanova OA
Cancer Res; 2021 Jan; 81(2):254-263. PubMed ID: 33087320
[TBL] [Abstract][Full Text] [Related]
34. Somatic alterations and dysregulation of epigenetic modifiers in cancers.
Aumann S; Abdel-Wahab O
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):24-34. PubMed ID: 25111821
[TBL] [Abstract][Full Text] [Related]
35. Epigenetics in normal and malignant hematopoiesis: An overview and update 2017.
Goyama S; Kitamura T
Cancer Sci; 2017 Apr; 108(4):553-562. PubMed ID: 28100030
[TBL] [Abstract][Full Text] [Related]
36. Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women.
Wiedmeier JE; Kato C; Zhang Z; Lee H; Dunlap J; Nutt E; Rattray R; McKay S; Eide C; Press R; Mori M; Druker B; Dao KH
Exp Hematol; 2016 Sep; 44(9):857-865.e5. PubMed ID: 27235757
[TBL] [Abstract][Full Text] [Related]
37. [The significance of the epigenetics modifying gene mutations in acute myeloid leukemia].
Wakita S; Yamaguchi H
Nihon Rinsho; 2014 Jun; 72(6):1026-32. PubMed ID: 25016799
[TBL] [Abstract][Full Text] [Related]
38. NSD2 as a Promising Target in Hematological Disorders.
Azagra A; Cobaleda C
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232375
[TBL] [Abstract][Full Text] [Related]
39. [Involvement of aberrant DNA methylation in hematological malignancies].
Matsui H
Rinsho Ketsueki; 2014 Oct; 55(10):1709-14. PubMed ID: 25297731
[No Abstract] [Full Text] [Related]
40. MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia.
Riedel SS; Haladyna JN; Bezzant M; Stevens B; Pollyea DA; Sinha AU; Armstrong SA; Wei Q; Pollock RM; Daigle SR; Jordan CT; Ernst P; Neff T; Bernt KM
J Clin Invest; 2016 Apr; 126(4):1438-50. PubMed ID: 26927674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]